|
|
HR |
95%CI |
P |
|
HR |
95%CI |
P |
Time to fist recurrence
(months)
|
Time to fist recurrence
(months)
|
Time to fist recurrence
(months)
|
Time to fist recurrence
(months)
|
|
|
|
|
|
<12 vs ≥12 |
|
3.91 |
1.68-9.10 |
0.001 |
|
4.60 |
1.49-14.41 |
0.008 |
FIGO stage |
|
|
|
|
|
|
|
|
II-IV vs I |
|
2.64 |
0.98-7.13 |
0.047 |
|
1.48 |
0.39-5.53 |
0.563 |
Diameter of largest mass
found at SCS (cm)
|
Diameter of largest mass
found at SCS (cm)
|
Diameter of largest mass
found at SCS (cm)
|
Diameter of largest mass
found at SCS (cm)
|
Diameter of largest mass
found at SCS (cm)
|
|
|
|
|
≥5 vs <5 |
|
1.23 |
0.53-2.86 |
0.629 |
|
1.68 |
0.56-5.04 |
0.359 |
Isolated site* |
|
|
|
|
|
|
|
|
No vs Yes |
|
1.57 |
0.69-3.58 |
0.281 |
|
1.13 |
0.41-3.15 |
0.813 |
Multiple locations |
|
|
|
|
|
|
|
|
Yes vs No |
|
2.07 |
0.82-5.21 |
0.116 |
|
4.58 |
1.42-14.77 |
0.011 |
Non-genital organs surgeries |
Non-genital organs
surgeries |
Non-genital organs surgeries |
|
|
|
|
|
|
Yes vs No |
|
2.12 |
0.96-4.69 |
0.057 |
|
2.34 |
0.79-6.97 |
0.125 |
Residual tumor |
|
|
|
|
|
|
|
|
Yes vs No |
|
2.54 |
0.86-7.53 |
0.082 |
|
2.32 |
0.52-10.31 |
0.269 |
Adjuvant chemotherapy |
Adjuvant chemotherapy |
Adjuvant chemotherapy |
|
|
|
|
|
|
No vs Yes |
|
1.26 |
0.52-3.08 |
0.778 |
|
1.27 |
0.44-3.61 |
0.659 |